期刊
PHARMACEUTICS
卷 10, 期 2, 页码 -出版社
MDPI
DOI: 10.3390/pharmaceutics10020040
关键词
nose-to-brain delivery; neurological diseases; drug delivery systems; in situ-based gels; brain tumor; Alzheimer's disease
资金
- Medical Research Council (Self-Initiated Research) (MRC)
- National Research Foundation (NRF), South Africa
In situ-based gel drug delivery systems that can bypass the blood-brain barrier, deliver the therapeutics to the desired site, reduce peripheral toxicity and control drug release kinetics have been developed. Some of the therapeutics used to treat neurological diseases suffer from poor bioavailability. Preclinical reports from several researchers have proven that the delivery of drugs to the brain via the nose-to-brain route using in situ gels holds great promise. However, safety issues on the toxicity of the nasal mucosa, transportation of the drugs to specific brain regions and determination of the required dose are factors that must be considered when designing these gels. This review will be focused on in situ-based gels that are used for the delivery of therapeutics via the nose-to-brain route, preclinical reports and challenges.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据